ReShape Lifesciences Inc. (OBLN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-61.9	-21.6	-23.7	-37.4	-34.8	-20.5	-15.6	-9.9
Depreciation and amortization [+]	2.0	1.7	0.5	0.6	0.3	0.2	0.2	0.2
Depreciation	0.2	0.0	0.5	0.6	0.3	0.2	0.2	0.2
Amortization of intangible assets	1.7	1.7
Asset impairment charges	28.8
Stock-based compensation	12.8	1.3	3.0	4.7	3.2	0.6	0.2	0.2
Deferred taxes	-0.1	-0.1
Change in working capital [+]	-2.5	-0.1	4.0	2.6	-1.1	-0.3	3.4	3.2
Accounts receivable	-0.3	1.2	0.6	3.4	-4.2		0.1	0.1
Inventories	-0.4	-1.2	0.0	-0.2	-0.6	-0.5	0.1	-0.2
Other current assets	-0.4	0.8	0.4	0.1	-0.5	-1.0	0.0	-0.1
Accounts payable			-0.5	0.1	0.6	0.0	0.4
Deferred revenues				-0.2	0.4	0.1
Other	-1.5	-1.0	3.5	-0.6	3.2	1.0	2.8	3.4
Other operating activities	5.7	10.3	-6.6	0.1	1.7	0.7	0.4	-3.6
Cash from operations	-15.4	-8.6	-22.9	-29.4	-30.6	-19.4	-11.4	-9.9

Capital expenditures [+]	-0.4	-0.4	-0.2	-1.3	-1.0	-0.4	-0.1	-0.3
Purchases of property and equipment	-0.4	-0.4	-0.2	-1.3	-1.0	-0.4	-0.1	-0.3
Sales of property and equipment							0.0
Acquisitions	22.4	-2.0
Sales of short-term investments, net [+]			2.6	20.8	-20.8	6.6	2.9	-7.7
Purchases of short-term investments				-9.1	-94.6	-18.9	-18.6	-12.4
Sales of short-term investments			2.6	29.9	73.8	25.5	21.5	4.8
Other cash from investing	-20.1
Cash from investing	1.9	-2.4	2.4	19.5	-21.9	6.2	2.8	-7.9

Issuance of common stock, net			23.4	9.8		67.2
Option exercises	0.4		0.0	0.2	0.6	1.1	0.1	0.0
Financing costs	-3.2	-0.1
Other cash from financing	30.5	11.0	-10.0	0.4	1.2	16.6	5.1	22.2
Cash from financing	33.3	11.1	13.4	10.0	0.6	82.8	5.1	22.2

Free cash flow	-15.7	-8.9	-23.1	-30.7	-31.7	-19.7	-11.5	-10.2
Per share (diluted)	($1.27)	($2.29)	($4.90)	($16.13)	($1.89)	($4.67)	($20.12)	($19.15)

Cash paid for interest	0.3		0.7	0.6	0.6	0.5	0.5	0.2
Cash paid for income taxes	0.1	0.0